| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V0787 | S- (+)-Rolipram (ME-3167; SB95952; ZK-62711) | 85416-73-5 | S-(+)-Rolipram, theS-isomer of rolipram (ME3167;SB-95952; ZK62711), isa potent phosphodiesterase PDE4-inhibitor with potent anti-inflammatory and anti-depressant activity. |
|
V135116 | Enpp-1-IN-30 | Enpp-1-IN-30 is an ENPP1 inhibitor with high oral bioavailability, and its human IC50 value is 13.1 nM. | |
|
V0783 | GSK256066 | 801312-28-7 | GSK256066 (GSK-256066; GSK 256066) is a novel, potent and selective inhibitor of PDE4B (phosphodiesterase 4B) with important biological activity (e. |
|
V0792 | Mardepodect (PF-2545920; MP-10) | 898562-94-2 | Mardepodect (formerly known as PF-2545920, PF2545920, MP10; MP-10) is a novel, potent and selective PDE10A (phosphodiesterase) inhibitor with antipsychotic activity. |
|
V2648 | Mardepodect HCl (PF-2545920 HCl) | 2070014-78-5 | Mardepodect HCl, the hydrochloric acid salt of PF-2545920 (Also known as Mardepodect,MP-10), is a novel, potent and selective PDE10A (phosphodiesterase) inhibitor with IC50 of 0.37 nM, andwith >1000-fold selectivity over the PDE. |
|
V142262 | PAT-078 | 1682644-84-3 | PAT-078 is a type II autosecretin (ATX) inhibitor. |
|
V142333 | PDE3/4-IN-2 | 2857007-03-3 | PDE3/4-IN-2 is a dual inhibitor of PDE3A and PDE4B1, with an IC50 of 0.13 nM for PDE3A and 50 nM for PDE4B1. |
|
V142334 | PDE3/4-IN-3 | 2939748-69-1 | PDE3/4-IN-3 is an orally effective dual PDE3/4 inhibitor with IC50 values of 0.17 nM for PDE3A and ≤50 nM for PDE4B2. |
|
V142632 | Phosphodiesterase-IN-4 | Phosphodiesterase-IN-4 is a potent inhibitor of tyrosyl-DNA phosphodiesterase 1 (TDP1). | |
|
V144433 | RX-RA-69 | 77749-49-6 | RX-RA-69 is an orally effective platelet phosphodiesterase (PDE) inhibitor with an IC50 of 1 nM. |
|
V144915 | Sildenafil chlorosulfonyl | 139756-22-2 | Sildenafil chlorosulfonyl is an intermediate in the synthesis of sildenafil, a phosphodiesterase 5 (PDE5) inhibitor. |
|
V145068 | SMQ-03-20 | SMQ-03-20 is a highly bioavailable, selective, and potent PDE11A4 inhibitor that can cross the blood-brain barrier. | |
|
V2623 | TAK-063 (Balipodect) | 1238697-26-1 | Balipodect (formerly also known as TAK-063) is a novel,highly potent, orally bioavailable and selective phosphodiesterase 10A (PDE10A) inhibitor with potential usefulness inthe treatment of schizophrenia. |
|
V146830 | V11294 | 162278-10-6 | V11294 is a phosphodiesterase 4 (PDE4) inhibitor with a Ki value of 436 nM for human lung PDE4. |
|
V4577 | Udenafil | 268203-93-6 | Udenafil (formerly known as DA8159) isa novel and potent PDE5 inhibitor used in urology to treat erectile dysfunction. |
|
V0793 | Dyphylline | 479-18-5 | Dyphylline (also named as Diprophylline; Corphyllin;Lufyllin; Neothylline), a xanthine derivative with bronchodilator and vasodilator effects,is used in the treatment of respiratory disorders like cardiac dyspnea,asthma, and bronchitis. |
|
V0780 | Tadalafil (IC 351; Cialis) | 171596-29-5 | Tadalafil (formerly known as IC351; IC-351;trade name Cialis) is a potent, orally bioavailable, reversible and competitive small-molecule inhibitor of PDE-5 (phosphodiesterase 5) with the potential to treat erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension. |
|
V0796 | Irsogladine | 57381-26-7 | Irsogladine (MN1695; MN 1695; Gaslon; MN-1695; Dicloguamine),a mucosal protective drug, is a novel and potent PDE4 inhibitor and muscarinic acetylcholine receptor binder with anti-ulceric activity. |
|
V0782 | Pimobendan | 74150-27-9 | Pimobendan (UD-CG115; UDCG115;Trade names Vetmedin, Acardi), a veterinary medication approvedto treat CHF-congestive heart failure in dogs, is a potent and selective inhibitor ofphosphodiesterasePDE3 with positive inotropic and vasodilator effects. |
|
V0790 | Dipyridamole ( NSC-515776; RA-8; Persantine) | 58-32-2 | Dipyridamole (also known as NSC515776; RA8; Persantine) is a pyrimido-pyrimidine based phosphodiesterase (PDE) inhibitor with antiplatelet properties. |